JULIO AVILA: Open Payments
NPI 1841503711 · DONNA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 64 payments from 8 companies in 2025. Trend: 2023 $813 · 2024 $1,359 · 2025 $1,111
Food & beverage: $1,111
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $257 |
| AstraZeneca Pharmaceuticals LP | 11 | $234 |
| Lilly USA, LLC | 17 | $227 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $176 |
| Novo Nordisk Inc | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Exact Sciences Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
Products named: FARXIGA, OTEZLA, MOUNJARO, Kerendia, Ozempic, JARDIANCE, REPATHA, Rybelsus.
Industry payments across TX — which companies pay providers there.
